Skip to main content

Geneos Therapeutics

Plymouth Meeting, United States

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

$5.0M raised
Sep 2023
Series A

Top Investors

Sante Ventures3B Future Health FundKorea Investment PartnersInovio PharmaceuticalsShanghai Healthcare Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Geneos Therapeutics

How much funding has Geneos Therapeutics raised?
Geneos Therapeutics has raised $5.0M in total funding. The most recent round was Series A. The last funding was announced in September 2023.
Who are Geneos Therapeutics's investors?
Geneos Therapeutics's investors include Sante Ventures, 3B Future Health Fund, Korea Investment Partners, Inovio Pharmaceuticals, Shanghai Healthcare Capital.
Where is Geneos Therapeutics headquartered?
Geneos Therapeutics is headquartered in Plymouth Meeting, United States.
What does Geneos Therapeutics do?
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
What stage is Geneos Therapeutics at?
Geneos Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Geneos Therapeutics — Funding & Investors." VCBacked, September 27, 2023, https://www.vcbacked.co/company/geneos-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2023). Geneos Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/geneos-therapeutics
Wikipedia (cite web)
{{cite web |title=Geneos Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/geneos-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .